• Tue. Oct 27th, 2026

developed

  • Home
  • Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut

Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut

Researchers at Michigan Medicine have successfully reversed a severe and often intractable form of fatty liver disease in animal studies by focusing on an unexpected entry point for hepatic damage:…

Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut

An experimental drug developed by researchers at Michigan Medicine has successfully reversed a severe and often intractable form of fatty liver disease in animal studies. Rather than focusing exclusively on…